Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03398772
Other study ID # N201704032
Secondary ID
Status Recruiting
Phase N/A
First received January 2, 2018
Last updated April 24, 2018
Start date March 1, 2018
Est. completion date July 31, 2020

Study information

Verified date November 2017
Source Taipei Medical University
Contact Huang Ya-Hsuan, PhD
Phone 0979306004
Email d432104001@tmu.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic obstructive pulmonary disease due to incurable and prevalence has increased steadily, chronic respiratory disease is considered hazardous to health and quality of life of the disease. GOLD treatment guidelines (global initiative for chronic obstructive lung disease guideline) pointed out the pulmonary rehabilitation is one of the non-drug treatment in patients with severe COPD, shown to improve exercise capacity and reduce the short of breathing, improve the quality of life and reduce the anxiety associated and depression and improved survival advantages. Meanwhile, a few studies have examined effect the exercise training in severe COPD patients' symptom distress and quality of life, so as to make severe COPD patients to improve the effectiveness of the campaign to ongoing regular pulmonary rehabilitation movement, is considered an important issue.

It has been proposed that physical activity enhancement or exercise training can be effective in improving symptoms and quality of life in these patients. However, it has not been examined systematically. Therefore, the main purposes of this study are: 1.Prevalence of symptom distress; 2.The physical preferences; 3.The relationship between quality of life and physical activity; 4.Effects of Comprehensive Health coaching exercise training on improving fatigue, sleep disturbances, quality of life, readmission, and survival. In the first year of this study, a descriptive-correlational design will be used and in the second and third years of study, the experimental design and prospective longitudinal study will be undertaken. Instruments include motion sensors, physical activity scale, Physical Activity Preferences, Pittsburgh Sleep Quality of Life Index. Statistical analyses include descriptive statistics, t-test, one-way ANOVA, latent growth modeling, Logistic models, GEE, and survival analysis. Results from this study will provide important implications for improving symptom management and quality of life for sever chronic obstructive pulmonary disease patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date July 31, 2020
Est. primary completion date July 31, 2020
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria:

- age =40 years and ?80 years

- patients with advanced COPD are defined according to the diagnostic criteria for severe (GOLD 3) and very severe (GOLD 4)

- pulmonologist assess need pulmonary rehabilitation, but not accept any rehabilitation exercise program.

- pulmonologist assessment the patients with a stable state.

- awareness, has the ability to read, write, and communication.

- willing to communicate by phone, and can operate smart phones.

Exclusion Criteria:

- COPD AE requiring corticosteroids, antibiotics, emergency room visit or hospitalization within the past 3 month.

- diagnosed mentally or cognitive disorder, such as dementia or unable to cooperate.

- severe hip, knee disease, can not perform exercise, or with neuromuscular dysfunction, such as limb hemiplegia, no independent walking function or other deterioration due to bone and joint disease.

- combined with severe heart disease, such as AMI, severe arrhythmia or heart failure.

- current regular practice of physical activity

Study Design


Intervention

Behavioral:
Comprehensive Health Coaching Program
Comprehensive Health Coaching Program: included physical activity and motivational interviewing techniques, participants were encouraged to set goals with decision-making, self-management and self-monitor their progress, and received support from researcher.

Locations

Country Name City State
Taiwan Taipei Medical Hospital-Shuang Ho Hospital,Ministry of Health and Welfare Taipei

Sponsors (1)

Lead Sponsor Collaborator
Taipei Medical University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Lung function at 3 months, 6months Spirometry (FEVl % predicted ) 3 months, 6months
Primary Change from Baseline Exercise Tolerance at 3 months, 6months 6 Minute walking test 3 months, 6months
Secondary Change from Baseline Health-related quality of life at 3 months, 6months St. George's Respiratory Questionnaire 3 months, 6months
Secondary Change from Baseline Fatigue at 3 months, 6months Brief Fatigue Inventory Short Form BFI-Taiwan Form 3 months, 6months
Secondary Change from Baseline Psychological distress at 3 months, 6months Hospital Anxiety and Depression Scale 3 months, 6months
Secondary Change from Baseline Symptom Distress at 3 months, 6months Taiwanese version of the M. D. Anderson Symptom Inventory 3 months, 6months
Secondary Change from Baseline Quality of Sleep at 3 months, 6months Taiwanese version of the Pittsburgh Sleep Quality Index 3 months, 6months
Secondary Readmission rate Survival pulmonologists blinded to allocation reviewed admission summaries and information to determine as COPD related readmission or mortality 1 year
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03923660 - Ventilatory Adaptation to Concentric Versus Eccentric Exercise in Patients With Severe COPD N/A
Recruiting NCT06008210 - A Decision Aid on End-of-life Care for Patients With Advanced COPD and Their Family N/A
Recruiting NCT05029349 - Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease) N/A
Not yet recruiting NCT05539547 - Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD Early Phase 1
Recruiting NCT04018729 - Cell Therapy Associated With Endobronchial Valve Phase 2/Phase 3
Suspended NCT04848012 - Efficacy of an Advanced Auto-titrating NIV in COPD N/A
Recruiting NCT06198309 - Risk Prediction Model for Exacerbating Phenotype in Patients With Chronic Obstructive Pulmonary Disease
Recruiting NCT06247397 - Effect of HIgh-flow Therapy in Long-term Oxygen Therapy N/A
Completed NCT05259280 - Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD N/A
Not yet recruiting NCT06212765 - Oral Citrulline Supplementation in COPD Patients With Malnutrition Phase 3
Completed NCT02962999 - Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation Phase 4
Not yet recruiting NCT06229509 - Study of the Cytokine Response During Exercise Dyspnea in Patients With Chronic Obstructive Pulmonary Disease (COPD). Effect of Body Composition N/A
Completed NCT05431218 - Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD Phase 4
Recruiting NCT04069312 - Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) Phase 4
Recruiting NCT05575336 - Assessment of the Effectiveness, Socio-economic Impact and Implementation of a Digital Solution for Severe Patients N/A
Completed NCT02998515 - Effects of Different Oxygen Devices in Hypoxemic COPD Patients N/A
Completed NCT04533516 - Additional Manual Therapy Over Inspiratory Muscle Training in COPD N/A
Recruiting NCT06072690 - Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease